It has been suggested that tumor-promoting inflammation and antitumor immunity coexist at different points along the path of tumor progression [49], and a recent report has demonstrated that CDH11 was a key mediator of fibroblast inflammation [50]. The gene discussed is CDH11; the disease is neoplasm.